Protecting All Species, But Mostly Humans
SeqOnce makes assays and reagents for researchers and clinicians that are rapid and informative, from cutting-edge NGS products used in organ transplants, to qPCR assays that detect infectious disease.
We emphasize installation and support and can hold critical reserve inventory for you, with rapid on-demand delivery to your site.
LATEST NEWS AND BLOG POSTS
SeqOnce Biosciences Launches AzureSeq Direct Saliva for Detection of SARS-CoV-2
New assay for symptomatic and asymptomatic individuals detects SARS-CoV-2 in saliva without extraction February 3, 2022 SeqOnce Biosciences announces the launch of a new kit and controls for screening symptomatic and asymptomatic individuals for COVID-19 [...]
SeqOnce Biosciences Announces AzureSeq RT-qPCR Assay to Detect SARS-CoV-2 E484K Variant of Concern
New assay detects Brazilian and South African SARS-CoV-2 variant faster than sequencing, screens more samples Pasadena, CA., Mar 8, 2021- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit [...]
SeqOnce BioSciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant
Assay quickly identifies mutation found in U.K. SARS-CoV-2 N501Y Pasadena, CA., Jan 27, 2021- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel [...]